Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $5.3136 per EA under NDC 00054065025. Its NADAC has been published 179 times since Mar 22, 2023.
FDA first approved this application on Jan 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP
Butalbital, Acetaminophen, Caffeine and Codeine PhosphateStrength
300; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054065025
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA215138FDA Approved
1/26/2022
TE Code
AB
On Market Since
5/9/2022
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has been published 179 times since Mar 22, 2023, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3136 per EA |
|---|---|
| All-time high | $5.6960 (Apr 10, 2024) |
| All-time low | $4.1553 (Feb 19, 2025) |
| 52-week high | $5.3507 |
| 52-week low | $4.9748 |
| Median price | $5.2291 |
| Average price | $5.1847 |
| Largest weekly change | -11.0% (Jul 17, 2024) |
| Weeks tracked | 179 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Butalbital, Acetaminophen, Caffeine and Codeine Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP, manufactured by Hikma Pharmaceuticals USA Inc., is $5.3136 per EA (NDC 00054065025), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has declined 6.7%. It has been tracked across 179 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
Since Mar 22, 2023, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP has ranged from a low of $4.1553 (Feb 19, 2025) to a high of $5.6960 (Apr 10, 2024), with a median of $5.2291 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP (NDC 00054065025) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.